In response to the COVID-19 pandemic, several research infrastructures (RIs) have set up specific services, such as rapid or fast track access, to allow researchers to obtain results as soon as possible. To facilitate their use by researchers, we would like to collect the relevant information about the initiatives on a dedicated website.
To help the research community find suitable support, we are collecting information about the relevant services. We invite research infrastructures to inform us about their service by filling in the questionnaire.
This work is carried out by CERIC in the frame of ACCELERATE, funded by the European Union Framework Programme for Research and Innovation Horizon 2020, under grant agreement 731112. For more information, please contact: firstname.lastname@example.org.
Last update: 15/09/2020 at 17:10
The documents with details about each RI's services are included in the list below.
> The summary table within each category provides a detailed overview of the COVID-19 services of RIs that submitted their input in the questionnaire.
National Hydrogen Centre CNH2: Hydrogen and fuel cell developments covering the whole value chain. CNH2 provides rapid access to laboratories and services, such as laser cutting machines, 3d printers and machining centres. (Details about the service here).
ERINHA, the European Research Infrastructure on Highly Pathogenic Agents, offers access to high containment facilities (BSL3 & BSL4) for in vitro and in-vivo pre-clinical research on SARS-CoV-2/COVID-19. (Details about the service here).
EVA: The European Virus Archive (EVA-Global) is a virtual collection for human, animal and plant viruses, that provides researchers with the necessary material for diagnosing coronavirus infection. EVA provides access provision of COVID-19 virus and related reagents for the molecular and serological detection of the virus in clinical samples. (Details about the service here).
IRTA-CReSA is a public research institute devoted to research in animal health following the One Health concept. It supports research in animal health field but also human health, animal models for human infectious diseases, inactivation viral studies, antiviral assays, and vaccine development and testing. (Details about the service here).
– ESFRI: Find here the ESFRI’s dedicated webpage for COVID-19 resources and activities.
– ERIC Forum: Find here the overview of ERICs’ COVID-19 initiatives.
– LENS: Find here how LENS fight against COVID-19 using neutrons.
– LEAPS: Find here the COVID-19 rapid accesses at LEAPS member facilities.
– European Life Science Research Infrastructures: Find here details about the services.
– Lightsource.org: Find here the SARS-CoV-2 publications of light source facilities.
 Infrastructures that are open for international users and include national infrastructures as well as European networks and consortia of research infrastructures.
This page is being updated on a daily basis, however, considering the COVID-19 situation is constantly evolving, we kindly ask you to refer to the website of each Research Infrastructure for the latest updates.
Find here the ESFRI’s dedicated webpage for COVID-19 resources and activities.
The SARS-CoV-2 illustration in the above banner was created at the Centers for Disease Control and Prevention (CDC) and it reveals ultrastructural morphology exhibited by coronaviruses. Image by: CDC/ Alissa Eckert, MS; Dan Higgins, MAMS